David Millson

1.6k total citations
45 papers, 1.1k citations indexed

About

David Millson is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, David Millson has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 13 papers in Pathology and Forensic Medicine and 10 papers in Physiology. Recurrent topics in David Millson's work include Migraine and Headache Studies (20 papers), Trigeminal Neuralgia and Treatments (7 papers) and Sympathectomy and Hyperhidrosis Treatments (7 papers). David Millson is often cited by papers focused on Migraine and Headache Studies (20 papers), Trigeminal Neuralgia and Treatments (7 papers) and Sympathectomy and Hyperhidrosis Treatments (7 papers). David Millson collaborates with scholars based in United Kingdom, United States and Singapore. David Millson's co-authors include Helen Boardman, Elaine Thomas, Stewart J. Tepper, Peter Croft, Darren M. Ashcroft, Pam Smith, Upendra Singh, John J. T. Owen, Peter J. Goadsby and Jan Erik Hardebo and has published in prestigious journals such as Neurology, European Journal of Immunology and Lara D. Veeken.

In The Last Decade

David Millson

45 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Millson United Kingdom 18 619 390 353 90 81 45 1.1k
Cynthia A. Stuenkel United States 26 264 0.4× 473 1.2× 102 0.3× 132 1.5× 51 0.6× 68 2.6k
Maggie Dailey United States 8 207 0.3× 265 0.7× 147 0.4× 40 0.4× 49 0.6× 8 1.5k
Timothy R. Smith United States 19 842 1.4× 460 1.2× 453 1.3× 165 1.8× 288 3.6× 44 1.7k
Maja Živković Serbia 22 243 0.4× 120 0.3× 141 0.4× 82 0.9× 103 1.3× 156 1.5k
Fotios Dimitriadis Greece 23 267 0.4× 126 0.3× 146 0.4× 242 2.7× 81 1.0× 105 1.6k
J. B. Ruidavets France 17 119 0.2× 180 0.5× 245 0.7× 72 0.8× 34 0.4× 28 1.4k
F Grodstein United States 17 114 0.2× 222 0.6× 253 0.7× 81 0.9× 34 0.4× 32 1.4k
P Wicker United States 18 578 0.9× 55 0.1× 109 0.3× 131 1.5× 65 0.8× 29 1.3k
Leigh Ann White United States 16 305 0.5× 184 0.5× 187 0.5× 27 0.3× 231 2.9× 23 1.1k
Nunziata Morabito Italy 21 100 0.2× 572 1.5× 195 0.6× 114 1.3× 64 0.8× 42 1.9k

Countries citing papers authored by David Millson

Since Specialization
Citations

This map shows the geographic impact of David Millson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Millson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Millson more than expected).

Fields of papers citing papers by David Millson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Millson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Millson. The network helps show where David Millson may publish in the future.

Co-authorship network of co-authors of David Millson

This figure shows the co-authorship network connecting the top 25 collaborators of David Millson. A scholar is included among the top collaborators of David Millson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Millson. David Millson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Martín, Paul, Stuart Oliver, Michael Gillen, Thomas Marbury, & David Millson. (2015). Pharmacokinetic Properties of Fostamatinib in Patients With Renal or Hepatic Impairment: Results From 2 Phase I Clinical Studies. Clinical Therapeutics. 37(12). 2823–2836. 11 indexed citations
4.
Martin, Paul, Michael Gillen, David Millson, et al.. (2015). Effects of Fostamatinib on the Pharmacokinetics of Digoxin (a P-Glycoprotein Substrate): Results From in Vitro and Phase I Clinical Studies. Clinical Therapeutics. 37(12). 2811–2822. 15 indexed citations
5.
Weinblatt, M., Mark C. Genovese, M. Ho, et al.. (2013). Oskira-1: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Methotrexate. Data Archiving and Networked Services (DANS). 65. 7 indexed citations
6.
Boardman, Helen, et al.. (2006). The Natural History of Headache: Predictors of Onset and Recovery. Cephalalgia. 26(9). 1080–1088. 62 indexed citations
7.
Boardman, Helen, Elaine Thomas, David Millson, & Peter Croft. (2005). Psychological, Sleep, Lifestyle, and Comorbid Associations With Headache. Headache The Journal of Head and Face Pain. 45(6). 657–669. 98 indexed citations
8.
9.
Thomas, Elaine, et al.. (2004). Advice and Care for Headaches: Who Seeks it, Who Gives it?. Cephalalgia. 24(9). 740–752. 14 indexed citations
10.
Ashcroft, Darren M. & David Millson. (2003). Naratriptan for the treatment of acute migraine: meta‐analysis of randomised controlled trials. Pharmacoepidemiology and Drug Safety. 13(2). 73–82. 28 indexed citations
11.
Phelan, Michael, et al.. (2002). A community pharmacy based survey of users of over the counter sleep aids. Pharmaceutical journal/˜The œpharmaceutical journal. 269(7213). 287–290. 11 indexed citations
12.
Frischer, Martin, et al.. (2001). Trends in antibiotic prescribing and associated indications in primary care from 1993 to 1997. Journal of Public Health. 23(1). 69–73. 24 indexed citations
13.
Frischer, Martin, H. Heatlie, David Millson, et al.. (2000). A comparison of trends in problematic drug misuse from two reporting systems. Journal of Public Health. 22(3). 362–367. 10 indexed citations
14.
Frischer, Martin, et al.. (2000). Ratio of Inhaled Corticosteroid to Bronchodilator Treatment and Asthma Hospitalisation. Current Medical Research and Opinion. 16(1). 8–13. 6 indexed citations
15.
Millson, David, Martin Frischer, P Croft, & Peter J. Goadsby. (2000). Are Triptans with Enhanced Lipophilicity Used for the Acute Treatment of Migraine Associated with an Increased Consulting Rate for Depressive Illness?. Cephalalgia. 20(8). 732–737. 6 indexed citations
16.
Millson, David, Stewart J. Tepper, & Alan M. Rapoport. (2000). Migraine pharmacotherapy with oral triptans: a rational approach to clinical management. Expert Opinion on Pharmacotherapy. 1(3). 391–404. 30 indexed citations
17.
Frischer, Martin, et al.. (1999). Should the corticosteroid to bronchodilator ratio be promoted as a quality prescribing marker?. Public Health. 113(5). 247–250. 15 indexed citations
18.
Millson, David. (1999). How effective are triptans in the treatment of episodic and chronic cluster headache. The Italian Journal of Neurological Sciences. 20(S1). S69–S71. 2 indexed citations
19.
Tepper, Stewart J., et al.. (1999). A Long-term Study to Maximise Migraine Relief with Zolmitriptan. Current Medical Research and Opinion. 15(4). 254–271. 45 indexed citations
20.
Millson, David, et al.. (1991). The effects of a 5‐HT2 receptor antagonist (ICI 169,369) on changes in waking EEG, pupillary responses and state of arousal in human volunteers.. British Journal of Clinical Pharmacology. 32(4). 447–454. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia A. Stuenkel Breakdown of academic impact, for papers by Maggie Dailey Breakdown of academic impact, for papers by Timothy R. Smith Breakdown of academic impact, for papers by Maja Živković Breakdown of academic impact, for papers by Fotios Dimitriadis Breakdown of academic impact, for papers by J. B. Ruidavets Breakdown of academic impact, for papers by F Grodstein Breakdown of academic impact, for papers by P Wicker Breakdown of academic impact, for papers by Leigh Ann White Breakdown of academic impact, for papers by Nunziata Morabito
Rankless by CCL
2026